The INTELLANCE 2 protocol was a randomized multicentric study which analyzed the efficacy of Depatux-M alone versus Depatux-M plus TMZ versus the standard treatment of lomustine or TMZ in EGFR-amplified GBM patients relapsing after the Stupp protocol [16]. Here, EGFR is linked to glioblastoma.